Boehringer Ingelheim Pharma GmbH & Co KG has described stimulator of interferon genes protein (STING; TMEM173) antagonists reported to be useful for the treatment of glaucoma, rheumatoid arthritis, ...

It's one of the most common causes of vision loss, and one of the easiest to overlook. Glaucoma symptoms develop so gradually ...

Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...

Tera P90 is knocking on your door. It is there, waiting, with three other siblings. For registered members, the different ...

Low-concentration bimatoprost 0.01%/timolol 0.1% eye gel is noninferior to the higher-concentration 0.03%/0.5% eye drops for IOP-lowering.

We are proud to continuously support the study of interventional glaucoma treatment, especially in highlighting critical groups of patients that may benefit from active surgical interventions. These ...

Sociodemographic factors, including residence in a socioeconomically distressed or rural area, can make it more likely that patients will present with advanced glaucoma.

Founded to accelerate innovation in glaucoma treatment, Glaucoma 360 is GRF’s signature event and one of the vision community’s most anticipated annual gatherings. The three-day program features a ...

Ophthalmologists discuss how advanced imaging, MIGS, and home monitoring are reshaping decision-making in complex glaucoma ...

BOZEMAN, MT – November 04, 2025 – PRESSADVANTAGE – Glaucoma continues to be one of the most significant causes of vision loss across the country, often developing slowly and without obvious warning ...

Glaucoma remains one of the leading causes of blindness in the United States, often progressing silently until vision loss has already occurred. Known as the “silent thief of sight,” the disease ...